Study on Clinical Features, Treatment Mode and Survival of Bone and Soft Tissue Tumors
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: NO Intervention.
- Who it may be relevant to
- Registry conditions: Bone and Soft Tissue Tumors, Clinical Features. Basic parameters: 6 years — 99 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Single-center Real World Prospective Observational Study of Clinical Features, Treatment Patterns, and Survival of Bone and Soft Tissue Tumors
Overview
It is planned to prospectively collect, collate and report real-world clinical data of BSTS patients treated in our hospital in the next ten years to evaluate the changes in clinical characteristics, treatment patterns and survival information of these patients, in order to provide reference for clinical treatment and research of this type of tumor.
Detailed description
It is planned to prospectively collect, collate and report real-world clinical data of BSTS patients treated in our hospital in the next ten years to evaluate the changes in clinical characteristics, treatment patterns and survival information of these patients, in order to provide reference for clinical treatment and research of this type of tumor. This study is a single-center, prospective, real-world observational study that plans to enroll all eligible patients. Basic information, treatment methods, and prognostic information of these patients were collected.
Interventions
- Other NO Intervention
NO Intervention
Primary outcome measures
- Overall survival [Time frame: Up to approximately 120months]
- 6/5000 Progression-free survival [Time frame: Up to approximately 48months]
Eligibility criteria
Inclusion criteria
All ages, male and female.
The pathological diagnosis of BSTS in our hospital was a subtype.
Has received at least one hospitalization in this hospital.
The target lesions could be evaluated according to the efficacy evaluation criteria of solid tumor (RECIST; Version 1.1) Measure diameter changes.
Exclusion criteria
No definite pathology.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
China · 1 center
- Department of Bone and Soft Tissue ,Henan Cancer Hospital — Zhengzhou
Identifiers
NCT: NCT05468970 · ZZUSC-12